Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2022-01-18 00:00:00 ET · period of report 2022-01-04 · accession 0001209191-22-003502 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-18 | 2022-01-04 | CCCC | Dubin Glenn | Dir | A - Grant | $31.58 | +199 | 494 | +67% | +$6,284 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-04 | A | A | 199 | $31.58 | 494 | D | — | — | (F2) The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 4, 2022. |